High Throughput Long-Read Sequencer System Corrective/Remedial Repair and Preventive Maintenance Service

Solicitation / RFP / RFQ

This is a combined synopsis/solicitation for commercial items to procure a Service and Maintenance Agreement for a PacBio Revio High Throughput Long-Read Sequencer System. The U.S. Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR) Division of Genetic and Molecular Toxicology (DGMT) requires this service to support projects vital to public health, specifically for mutation analysis on biological samples. The system was previously covered by a service contract with Pacific Biosciences Of California, which expired on December 9, 2025.

• Corrective/Remedial Repair and Preventive Maintenance:

  • Services must be performed by formally trained and certified Original Equipment Manufacturer (OEM) technicians/engineers.
  • Must adhere to OEM specifications, manuals, and service bulletins, using OEM replacement parts.
  • Includes unlimited corrective/remedial and preventive maintenance, covering shipping, labor, travel, and replacement parts.
  • Requires at least one (1) on-site visit per year for routine instrument calibration/certification, including necessary consumable parts.
  • Provides for shipping arrangements and materials for parts that cannot be repaired on-site.
  • Corrective/remedial repair visits required within 2-3 business days of a service call for issues not resolvable remotely.
  • Unlimited technical support available Mondays-Fridays (excluding Federal Holidays) between 7:00 AM - 5:00 PM Central Time, with solutions to problems initiated within 8 business hours.
  • Manufacturer's call center must be accessible for technical assistance.
  • Includes access to OEM technical developments, repair procedure bulletins, and unlimited software, firmware, and application updates.

• Deliverables: Service Records and Reports detailing each service call or PM visit.

• Contract Type: Firm-Fixed-Price.

• Period of Performance:

  • Base Year: March 1, 2026 - February 28, 2027
  • Option Period 1: March 1, 2027 - February 29, 2028
  • Option Period 2: March 1, 2028 - February 28, 2029
  • Option Period 3: March 1, 2029 - February 28, 2030

• FOB Place of Performance: U.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, AR.

• Submission Deadline: Proposals/quotes and supporting documents are due by 1:00 PM Central Time on February 20, 2026.

• Submission Method: Via e-mail to howard.nesmith@fda.hhs.gov.

• Evaluation: Award will be made to the lowest price technically acceptable and responsible offeror. Evaluation will be based on Technical Acceptability and Price.

• Technical Acceptability: Determined by review of submitted information demonstrating the proposed service/equipment meets all technical requirements.

• Inspection: Offerors are afforded the opportunity to inspect the system by contacting the Contract Specialist/Contracting Officer to schedule an appointment.

• NAICS Code: 811210 - Electronic and Precision Equipment Repair and Maintenance.

• Small Business Size Standard: $34.0 million.

• Competition: This requirement is being competed unrestricted and made available to Full and Open competition.

• Offerors must register and be active in SAM.gov.

• Electronic documents submitted must not contain macros.

• The solicitation incorporates provisions by reference; full text is available electronically.

• Specific FAR and HHSAR clauses apply, including those related to System for Award Management, Service Contract Labor Standards, Buy American Act, and Section 508 accessibility standards for Information and Communication Technology.